General Catalyst Group Management, LLC
General Catalyst Group Management, LLC reported 13 holdings worth US$478M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
General Catalyst Group Management, LLC reported 13 holdings worth US$478M as of Sep 30, 2026. Largest: QUALCOMM Incorporated, Parabilis Medicines, Inc. and ArriVent BioPharma, Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 13
- Value as reported
- US$478M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| QUALCOMM Incorporated | 1.58M | US$291M | 60.9% |
| Parabilis Medicines, Inc. | 1.6M | US$51.7M | 10.8% |
| ArriVent BioPharma, Inc. | 1.49M | US$45.3M | 9.5% |
| Maplebear Inc. | 711K | US$30.6M | 6.4% |
| Maze Therapeutics, Inc. | 1.04M | US$28.2M | 5.9% |
| Odyssey Therapeutics, Inc. | 810K | US$18M | 3.8% |
| Oscar Health, Inc. | 300K | US$9.25M | 1.9% |
| Coupang, Inc. | 79,177 | US$1.1M | 0.23% |
| Meta Platforms, Inc. | 1,320 | US$957K | 0.20% |
| Amazon.com, Inc. | 3,532 | US$880K | 0.18% |
| Carvana Co. | 8,765 | US$548K | 0.11% |
| DoorDash, Inc. | 1,300 | US$239K | 0.05% |
| Martin Marietta Materials, Inc. | 175 | US$83,967 | 0.02% |
| Fractyl Health, Inc. | 0 | US$0 | 0.00% |
| Eikon Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Ethos Technologies Inc. | 0 | US$0 | 0.00% |
| Figma Inc | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC